更正：Viglianisi等人。唾液氧化应激生物标志物作为牙周炎预后标志物的新作用：牙科个性化方法的新见解。j·珀耳斯。医学杂志，2023,13,166。

IF 3 3区医学 Q2 HEALTH CARE SCIENCES & SERVICES

Journal of Personalized Medicine Pub Date : 2025-06-10 DOI:10.3390/jpm15060243

Gaia Viglianisi, Gianluca Martino Tartaglia, Simona Santonocito, Mariacristina Amato, Alessandro Polizzi, Marco Mascitti, Gaetano Isola

引用次数: 0

摘要

经过编辑委员会和作者的讨论，原始发表的参考文献编号为[…]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Correction: Viglianisi et al. The Emerging Role of Salivary Oxidative Stress Biomarkers as Prognostic Markers of Periodontitis: New Insights for a Personalized Approach in Dentistry. J. Pers. Med. 2023, 13, 166.

Following discussions between the Editorial Board and the authors, the original published references no [...].

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Personalized Medicine Medicine-Medicine (miscellaneous)

CiteScore

4.10

自引率

0.00%

发文量

1878

审稿时长

11 weeks

期刊介绍： Journal of Personalized Medicine (JPM; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. JPM publishes cutting edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., pharmacogenomics/proteomics, systems biology). JPM recognizes that personalized medicine—the assessment of genetic, environmental and host factors that cause variability of individuals—is a challenging, transdisciplinary topic that requires discussions from a range of experts. For a comprehensive perspective of personalized medicine, JPM aims to integrate expertise from the molecular and translational sciences, therapeutics and diagnostics, as well as discussions of regulatory, social, ethical and policy aspects. We provide a forum to bring together academic and clinical researchers, biotechnology, diagnostic and pharmaceutical companies, health professionals, regulatory and ethical experts, and government and regulatory authorities.